Application

NARCAN

Adapt Pharma Operations Limited

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 88863747
Filing Date: 04/08/020

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88863747
MARK INFORMATION
*MARK \\TICRS\EXPORT18\IMAGEOUT 18\888\637\88863747\xml1\ APP0002.JPG
SPECIAL FORM YES
USPTO-GENERATED IMAGE NO
LITERAL ELEMENT NARCAN
COLOR MARK YES
COLOR(S) CLAIMED
(If applicable)
The color(s) magenta is/are claimed as a feature of the mark.
*DESCRIPTION OF THE MARK
(and Color Location, if applicable)
The mark consists of the word NARCAN in stylized font in the color magenta.
PIXEL COUNT ACCEPTABLE YES
PIXEL COUNT 640 x 828
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Adapt Pharma Operations Limited
INTERNAL ADDRESS 6th Floor
*MAILING ADDRESS 6 Earlsfort Terrace
*CITY Dublin 2
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY Ireland
*EMAIL ADDRESS officeactionstm@brinksgilson.com
LEGAL ENTITY INFORMATION
TYPE limited liability company
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY WHERE LEGALLY ORGANIZED Ireland
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION Pharmaceutical preparations, namely, opioid antagonists and narcotic antagonists; pharmaceutical and drug preparations for use in treatment of opiate, opioid or narcotic overdose
FILING BASIS SECTION 1(a)
       FIRST USE ANYWHERE DATE At least as early as 02/00/2016
       FIRST USE IN COMMERCE DATE At least as early as 02/00/2016
       SPECIMEN FILE NAME(S) \\TICRS\EXPORT18\IMAGEOUT 18\888\637\88863747\xml1\ APP0003.JPG
       SPECIMEN DESCRIPTION photograph of the goods and packaging
INTERNATIONAL CLASS 005 
*IDENTIFICATION Auto-injectors, syringes, intranasal drug delivery devices, spray pump devices for nasal delivery, and devices for nasal delivery, all pre-filled with pharmaceuticals, namely, opioid antagonists and narcotic antagonists and pharmaceutical and drug preparations for use in treatment of opiate, opioid or narcotic overdose; nasal spray preparations
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 044 
*IDENTIFICATION Medical and health information services; providing a website for patients, medical professionals, and pharmacists featuring information in the fields of health, medicine, opioids and narcotics, opioid antagonists and narcotic antagonists, drug overdoses, and emergency medical tips; providing a website featuring pharmaceutical drug information relating to diagnostic, prophylactic and therapeutic properties of naloxone, opioid antagonists and narcotic antagonists
FILING BASIS SECTION 1(a)
       FIRST USE ANYWHERE DATE At least as early as 02/01/2016
       FIRST USE IN COMMERCE DATE At least as early as 02/01/2016
       SPECIMEN FILE NAME(S)
       ORIGINAL PDF FILE SPE0-6386199126-20200217153240089125_._NARCAN_IC_44_Specimen_of_Use.pdf
       CONVERTED PDF FILE(S)
       (2 pages)
\\TICRS\EXPORT18\IMAGEOUT18\888\637\88863747\xml1\APP0004.JPG
        \\TICRS\EXPORT18\IMAGEOUT18\888\637\88863747\xml1\APP0005.JPG
       SPECIMEN DESCRIPTION page from website
ADDITIONAL STATEMENTS SECTION
ACTIVE PRIOR REGISTRATION(S) The applicant claims ownership of active prior U.S. Registration Number(s) 0808366 and 5160883.
ATTORNEY INFORMATION
NAME Virginia Wolk Marino
ATTORNEY DOCKET NUMBER 16622/358
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Brinks Gilson & Lione
STREET P. O. Box 10395
CITY Chicago
STATE Illinois
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 60610
PHONE 312-321-4200
FAX 312-321-4299
EMAIL ADDRESS officeactions@brinksgilson.com
OTHER APPOINTED ATTORNEY Jeffery A. Handelman, David S. Fleming, Howard S. Michael, Andrew J. Avsec, Jennifer Theis, Emily T. Kappers and Fan Cheng
CORRESPONDENCE INFORMATION
NAME Virginia Wolk Marino
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE officeactions@brinksgilson.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) vmarino@brinksgilson.com; rlamontagna@brinksgilson.com
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 2
APPLICATION FOR REGISTRATION PER CLASS 275
*TOTAL FEES DUE 550
*TOTAL FEES PAID 550
SIGNATURE INFORMATION
SIGNATURE /Jennifer L Fox/
SIGNATORY'S NAME Jennifer L. Fox
SIGNATORY'S POSITION SVP Legal Affairs and Deputy General Counsel
SIGNATORY'S PHONE NUMBER 2406313471
DATE SIGNED 04/08/2020



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)


Trademark/Service Mark Application, Principal Register

Serial Number: 88863747
Filing Date: 04/08/020

To the Commissioner for Trademarks:

MARK: NARCAN (stylized and/or with design, see mark)
The literal element of the mark consists of NARCAN. The color(s) magenta is/are claimed as a feature of the mark. The mark consists of the word NARCAN in stylized font in the color magenta.
The applicant, Adapt Pharma Operations Limited, a limited liability company legally organized under the laws of Ireland, having an address of
      6th Floor
      6 Earlsfort Terrace
      Dublin 2
      Ireland
      officeactionstm@brinksgilson.com

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 005:  Pharmaceutical preparations, namely, opioid antagonists and narcotic antagonists; pharmaceutical and drug preparations for use in treatment of opiate, opioid or narcotic overdose

In International Class 005, the mark was first used by the applicant or the applicant's related company or licensee or predecessor in interest at least as early as 02/00/2016, and first used in commerce at least as early as 02/00/2016, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in the class of listed goods/services, consisting of a(n) photograph of the goods and packaging.
Specimen File1

International Class 005:  Auto-injectors, syringes, intranasal drug delivery devices, spray pump devices for nasal delivery, and devices for nasal delivery, all pre-filled with pharmaceuticals, namely, opioid antagonists and narcotic antagonists and pharmaceutical and drug preparations for use in treatment of opiate, opioid or narcotic overdose; nasal spray preparations
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 044:  Medical and health information services; providing a website for patients, medical professionals, and pharmacists featuring information in the fields of health, medicine, opioids and narcotics, opioid antagonists and narcotic antagonists, drug overdoses, and emergency medical tips; providing a website featuring pharmaceutical drug information relating to diagnostic, prophylactic and therapeutic properties of naloxone, opioid antagonists and narcotic antagonists

In International Class 044, the mark was first used by the applicant or the applicant's related company or licensee or predecessor in interest at least as early as 02/01/2016, and first used in commerce at least as early as 02/01/2016, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in the class of listed goods/services, consisting of a(n) page from website.

Original PDF file:
SPE0-6386199126-20200217153240089125_._NARCAN_IC_44_Specimen_of_Use.pdf
Converted PDF file(s) (2 pages)
Specimen File1
Specimen File2



Claim of Active Prior Registration(s)
The applicant claims ownership of active prior U.S. Registration Number(s) 0808366 and 5160883.


The owner's/holder's proposed attorney information: Virginia Wolk Marino. Other appointed attorneys are Jeffery A. Handelman, David S. Fleming, Howard S. Michael, Andrew J. Avsec, Jennifer Theis, Emily T. Kappers and Fan Cheng. Virginia Wolk Marino of Brinks Gilson & Lione, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      P. O. Box 10395
      Chicago, Illinois 60610
      United States
      312-321-4200(phone)
      312-321-4299(fax)
      officeactions@brinksgilson.com
The docket/reference number is 16622/358.
Virginia Wolk Marino submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.

The applicant's current Correspondence Information:
      Virginia Wolk Marino
       PRIMARY EMAIL FOR CORRESPONDENCE: officeactions@brinksgilson.com
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): vmarino@brinksgilson.com; rlamontagna@brinksgilson.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $550 has been submitted with the application, representing payment for 2 class(es).

Declaration

Declaration Signature

Signature: /Jennifer L Fox/   Date: 04/08/2020
Signatory's Name: Jennifer L. Fox
Signatory's Position: SVP Legal Affairs and Deputy General Counsel
Payment Sale Number: 88863747
Payment Accounting Date: 04/08/2020

Serial Number: 88863747
Internet Transmission Date: Wed Apr 08 10:31:06 ET 2020
TEAS Stamp: USPTO/BAS-XX.XX.XXX.XXX-2020040810310620
8737-88863747-710a786b1375664b61b3716bff
2f5dd472cb7eb762bf759c9fa873ef925b3618a5
d-DA-31061798-20200326111126916668

Application [image/jpeg]

Application [image/jpeg]

Application [image/jpeg]

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed